April 26, 2017
Onxeo: Q1 2017 financial information and business update
Media
April 26, 2017
PharmAthene and Altimmune Announce Combined Company Approved for Trading on Nasdaq Global Market
April 26, 2017
GenSight Biologics reports its cash position as of March 31, 2017
April 25, 2017
Wilson Therapeutics presents promising neurological Phase 2 data for WTX101 at AAN meeting
April 25, 2017
Targovax ASA: First quarter 2017 results
April 24, 2017
Aarhus University Hospital in Denmark Purchases NBS System from Nexstim Plc
April 24, 2017
Wilson Therapeutics presented positive final Phase 2 data for WTX101 at EASL Annual Meeting
April 24, 2017
Clinigen and Onxeo initiate Managed Access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)
April 24, 2017
Capio acquires a Swedish eye specialist clinic in Stockholm
April 20, 2017
Onxeo receives the EnterNext Tech 40 Label